{"id":"CHEMBL1018","canonicalSmiles":"C/C=C(C(=C/C)/c1ccc(O)cc1)\\c1ccc(O)cc1","inchiKey":"NFDFQCUYFHCNBW-SCGPFSFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIENESTROL","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dienestrol","Estraguard","Hormofemin"],"synonyms":[".alpha.-dienestrol diacetate","Cycladiene","Dehydrostilbestrol","Dienestrol","Dienestrol diacetate, .alpha.-","Dienestrol trans-form","Dienestrol, .alpha.-","Dienoestrol","Dienol","Dinovex","Estragard","Estroral","Follidiene","Gynefollin","NSC-59809","Oestrasid","Oestrodiene","Oestroral","Restrol","Retalon"],"crossReferences":{"PubChem":["124883370","144203929","170465362","26746961","56422141","855694"],"Wikipedia":["Dienestrol"],"drugbank":["DB00890"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1947."}
{"id":"CHEMBL1021","canonicalSmiles":"NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N","inchiKey":"QEFAQIPZVLVERP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPAFENAC","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilevro","Nepafenac","Nevanac"],"synonyms":["AHR-9434","AL-6515","Nepafenac"],"crossReferences":{"DailyMed":["nepafenac"],"PubChem":["124896627","144206538","170465203"],"Wikipedia":["Nepafenac"],"drugbank":["DB06802"],"chEBI":["75922"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MP_0001845","MONDO_0003005","EFO_1001231","MONDO_0005129","HP_0000545","HP_0100014","EFO_0003770","EFO_0009321","HP_0000540","EFO_0003843","EFO_0005752","HP_0000616"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1055","canonicalSmiles":"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl","inchiKey":"JIVPVXMEBJLZRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTHALIDONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorthalidone","Hygroton","Thalitone"],"synonyms":["Chlortalidone","Chlortalidonum","Chlorthalidone","G-33182","NSC-69200","Natriuran","Phthalamudine"],"crossReferences":{"DailyMed":["chlorthalidone"],"PubChem":["11532862","170464745","26747917"],"Wikipedia":["Chlortalidone"],"drugbank":["DB00310"],"chEBI":["3654"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","HP_0003124","EFO_0001645","EFO_0004278","EFO_0000373","EFO_0000319","MONDO_0002462","EFO_0000537","EFO_0003913","EFO_0003914","MONDO_0001134","EFO_1001375","EFO_0003144","MONDO_0005147","EFO_0003884","EFO_0004255","EFO_0000612","EFO_0003763","MONDO_0005148","EFO_0000400","EFO_0000668"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 9 approved and 12 investigational indications."}
{"id":"CHEMBL11122","canonicalSmiles":"COc1nc(C(Cl)(Cl)Cl)c(Cl)c(O)c1Cl","inchiKey":"GUYGGZGIKZIRFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["519402"],"drugbank":["DB06331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187646","canonicalSmiles":"NCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"BABFYCSPNDKXRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERPHENAZINE 4-AMINOBUTYRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perphenazine 4-aminobutyrate"],"childChemblIds":["CHEMBL513521"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL11978","canonicalSmiles":"CNC(=O)c1cccnc1","inchiKey":"ZYVXHFWBYUDDBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINYL METHYLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicotinyl Methylamide","Nicotinyl methylamide"],"crossReferences":{"drugbank":["DB08840"],"chEBI":["64399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200516","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.Cl","inchiKey":"UPRWQSQENCASAD-HBBGHHHDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GONADORELIN HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1007","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Factrel"],"synonyms":["AY-24,031","AY-24031","Gonadorelin hcl","Gonadorelin hydrochloride","Luteinizing hormone-releasing factor dihydrochloride"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200574","canonicalSmiles":"[Cl-].[Na+]","inchiKey":"FAPWRFPIFSIZLT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aqsia (balanced salt soln)","Askina","Askina jet","Balanced salt","Broncho saline","Bss (balanced salt soln)","Flowfusor","Fresenius","Hypromellose in ringers soln","Iocare (balanced salt soln)","Irriclens","Isot saline","Labmist","Lockes","Macoperf","Miniversol","Muro 128","Nine lives","Normasol","Oft cusi antiedema","Optiflo s","Physiomer","Ringer's","Ringer-locke","S-chlor sf","Salex","Saline","Saline steripoule","Salinex","Slow sod","Sodiclor","Sodium chloride","Sodium chloride 14.6%","Sodium chloride 23.4%","Sterac","Steri-wash","Sterijet","Syrisal","Table Salt","Topiclens","Tubilux","Uriflex-s","Uriflex-sp","Uroclens","Vitaclean"],"synonyms":["0.9% nacl","0.9% saline","0.9% saline solution","10% sodium chloride injection","B1655","Isotonic","Isotonic saline","LS-1700","NSC-77364","Nacl 0.9%","Normal saline","RNS-60 COMPONENT SALINE","RNS60 COMPONENT SALINE","SALINE SOLUTION","Sea water","Sodium Chloride, Hypertonic","Sodium chloride","Sodium chloride solution","Sodium chloride, hypertonic"],"crossReferences":{"DailyMed":["sodium%20chloride"],"DrugCentral":["4198"],"Wikipedia":["Sodium_chloride"],"drugbank":["DB09153"],"chEBI":["26710"]},"childChemblIds":["CHEMBL2103896"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 9 approved and 311 investigational indications."}
{"id":"CHEMBL1200804","canonicalSmiles":"O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]","inchiKey":"KXZOIWWTXOCYKR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC POTASSIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cambia","Cataflam","Diclofenac potassium","Voltarol joint pain","Voltarol pain-eze","Voltarol pain-eze extra strgh","Voltarol rapid","Zipsor"],"synonyms":["CGP 45840B","CGP-45840B","Diclofenac potassium","Diclofenac potassium salt","Potassium diclofenac"],"crossReferences":{"DailyMed":["diclofenac%20potassium"],"chEBI":["4508"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0000685","EFO_1001139","EFO_0009454","HP_0002373","EFO_0000544","EFO_0009582","HP_0001945","EFO_0010072","HP_0100607","EFO_0003843","MONDO_0005178"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200806","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]","inchiKey":"CDBRNDSHEYLDJV-FVGYRXGTSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"NAPROXEN SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL154","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aleve","Anaprox","Anaprox ds","Naprelan","Naproxen sodium","Synflex"],"synonyms":["BAY-117031","BAY117031","BAYH6689","Naproxen sodium","Naproxen sodium anhydrous","Naproxen sodium salt","RS-3650"],"crossReferences":{"DailyMed":["naproxen%20sodium"],"PubChem":["11112047","11113013","144204325","170465301","50106619","85231338","855887"],"chEBI":["7477"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004274","EFO_0010072","EFO_0003898","HP_0003418","HP_0000132","EFO_0003843","EFO_1000941","EFO_0002609","MONDO_0005277","EFO_0009454","EFO_0000731","MONDO_0004975","EFO_0004616","HP_0100607","MONDO_0002258","MONDO_0005178","EFO_1001434"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 11 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201438","drugType":"Protein","blackBoxWarning":true,"name":"ALDESLEUKIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proleukin"],"synonyms":["Aldesleukin","Human interleukin-2","Human interleukin-2 125-serine","ILT-101","Ilt-101","Ilt-101 (low dose il-2)","Interleukin 2","Interleukin-2","Interleukin-2 aldesleukin","Interleukin-2(2-133),125-ser","Recombinant interleukin-2 human"],"crossReferences":{"DailyMed":["aldesleukin"],"DrugCentral":["5011"]},"linkedTargets":{"rows":["ENSG00000134460","ENSG00000100385"],"count":2},"linkedDiseases":{"rows":["EFO_1000403","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1000984","EFO_1001951","MONDO_0000548","EFO_0000339","EFO_0000564","EFO_0002690","EFO_0000588","EFO_0000096","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0001668","MONDO_0004976","MONDO_0024885","EFO_0000198","EFO_0000221","MONDO_0013730","EFO_1001806","EFO_0000180","EFO_0000384","MONDO_0008315","MONDO_0002691","MONDO_0000544","EFO_0000574","EFO_0001378","EFO_0001376","EFO_0005672","EFO_0001062","EFO_1001465","MONDO_0007254","MONDO_0002158","MONDO_0002050","MONDO_0002898","EFO_0000183","EFO_0000616","EFO_0000765","EFO_0006859","EFO_1001779","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_0000222","MONDO_0007576","EFO_0004599","EFO_1000954","EFO_1001471","EFO_0000764","MONDO_0002367","MONDO_0018906","EFO_0007141","MONDO_0024880","MONDO_0024475","EFO_0000729","EFO_0003869","EFO_0001075","EFO_0003780","MONDO_0000956","EFO_1000131","EFO_1001148","EFO_0000565","EFO_0000309","EFO_0004251","HP_0001871","EFO_0009709","EFO_0000389","EFO_0000182","EFO_0000330","EFO_0000783","EFO_0004255","EFO_1000785","EFO_0004719","EFO_0003802","EFO_0003893","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0000223","Orphanet_3389","MONDO_0044881","EFO_0003025","EFO_0004239","EFO_0009708","MONDO_0019956","MONDO_0100096","EFO_0004192","EFO_0002428","EFO_1001051","EFO_0000218","EFO_0003812","MONDO_0015686","EFO_1001945","EFO_1001264","MONDO_0002087","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","EFO_0008518","Orphanet_906","EFO_0005531","EFO_0005846","EFO_0000673","EFO_0003047","EFO_0002617","EFO_1000158","EFO_1000616","EFO_0000313","EFO_0000621","EFO_0003029","EFO_0003060","EFO_0000311","EFO_0003865","EFO_0006861","EFO_0000095","MONDO_0005147","EFO_0001421","MONDO_0003219","MONDO_0020077","EFO_0000691","EFO_0003811","EFO_0003027"],"count":126},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved and 101 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1204628","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XOFLBQFBSOEHOG-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1204628","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01864"],"chEBI":["43000"]},"childChemblIds":["CHEMBL1627119"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1214598","canonicalSmiles":"CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12","inchiKey":"KCFYEAOKVJSACF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMIFENOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbidol","Umifenovir"],"crossReferences":{"PubChem":["26662180"],"drugbank":["DB13609"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1233524","canonicalSmiles":"CN(C)CCN(C)[C@H]1COc2ccccc2-c2c(C3CCCCC3)c3ccc(C(=O)O)cc3n2C1","inchiKey":"YQUCBFIQSJVCOR-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-3281","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-3281","Mk 3281","Mk-3281"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1234276","canonicalSmiles":"O=S(=O)(O)CCN1CCOCC1","inchiKey":"SXGZJKUKBWWHRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234276","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4242518"],"drugbank":["DB03814"],"chEBI":["39408"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235478","drugType":"Small molecule","blackBoxWarning":false,"name":"PLATINUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.i. 77795","Metallic platinum","Platina l","Platinum","Platinum black","Platinum metallicum","Platinum powder","Platinum, elemental"],"crossReferences":{"chEBI":["33364"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1256686","canonicalSmiles":"CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O","inchiKey":"HIYAVKIYRIFSCZ-CYEMHPAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-23187","ANTIBIOTIC A-23187","Calcimycin"],"crossReferences":{"PubChem":["26732633","50104781","90341142"],"Wikipedia":["A23187"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1256717","canonicalSmiles":"Cc1cc(C)c(NC(=O)C[C@H](CC(=O)O)c2cccc3ccccc23)c(C(=O)N2CCC3(CCCC3)CC2)c1","inchiKey":"MFOOVZCXWVAWOV-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITRIGLUMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr-2945","Itriglumide"],"crossReferences":{"PubChem":["50111121"]},"childChemblIds":["CHEMBL1335406"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL128748","canonicalSmiles":"COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC","inchiKey":"ZMGUKFHHNQMKJI-CIOHCNBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLCURCUMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASCJ-9","CHC-004","Dimethylcurcumin","GO-Y-025","Go-Y025"],"crossReferences":{"drugbank":["DB06133"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1476245","canonicalSmiles":"CN[C@H](C)CCC=C(C)C","inchiKey":"XVQUOJBERHHONY-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXISOMETHEPTENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-isometheptene","Dexisometheptene","Isometheptene, (r)-","TNX-200"],"crossReferences":{"PubChem":["124893653","50125852"]},"childChemblIds":["CHEMBL3707373"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1522","canonicalSmiles":"CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1","inchiKey":"GBBSUAFBMRNDJC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESZOPICLONE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eszopiclone","Lunesta"],"synonyms":["(S)-ZOPICLONE","(S)-Zopiclone","Estorra","Eszopiclon","Eszopiclone","Eszopiclone civ","GSK-1755165","Zopiclone s-form"],"crossReferences":{"DailyMed":["eszopiclone"],"PubChem":["144205286","170465445","29215492","49666409"],"Wikipedia":["Eszopiclone"],"drugbank":["DB00402"],"chEBI":["53760"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0007191","EFO_1001892","EFO_0001358","EFO_0003918","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for insomnia and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1558","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl","inchiKey":"WFXFYZULCQKPIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZOSIN HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphavase 0.5","Alphavase 1","Alphavase 2","Alphavase 5","Hypovase","Hypovase b.d.","Kentovace","Minipress","Minipress xl","Prazosin hydrochloride"],"synonyms":["CP-12,299-1","CP-12299-1","NSC-292810","Prazosin hcl","Prazosin hydrochloride"],"crossReferences":{"DailyMed":["prazosin%20hydrochloride"],"PubChem":["26747647","26747648","50106894","50106895","50106896","56462999","572084","855727"],"chEBI":["8365"]},"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","HP_0000726","EFO_0000400","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for diabetes mellitus and hypertension."}
{"id":"CHEMBL1568057","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"MKFFGUZYVNDHIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL SULFATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL776","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alupent","Alupent obstetric","Metaproterenol sulfate","Prometa"],"synonyms":["Metaproterenol sulfate","Metaproterenol sulphate","Orciprenaline sulfate","Orciprenaline sulphate","TH-152"],"crossReferences":{"DailyMed":["metaproterenol%20sulfate"],"PubChem":["170466142","50106554"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for asthma and has 1 investigational indication."}
{"id":"CHEMBL1615779","canonicalSmiles":"N=C(N)NCc1cccc([131I])c1","inchiKey":"PDWUPXJEEYOOTR-JRGAVVOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE I 131","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azedra"],"synonyms":["(131i)-mibg","131 i-mibg","131i-mibg","3-iodobenzylguanidine (131i)","3-iodobenzylguanidine, i-131","I-131 metaiodobenzylguanidine","Iobenguane (131 i)","Iobenguane (131i)","Iobenguane i 131","Iobenguane i-131","Iobenguane, i-131","Iodine (131i) iobenguane","M131ibg","Metaiodobenzylguanidine i-131","Mibg i-131"],"crossReferences":{"DailyMed":["iobenguane%20i-131"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0024503","EFO_1000453","EFO_0000239","EFO_0000621"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1618116","canonicalSmiles":"CSc1nc2[nH]nc([N+](=O)[O-])c(=O)n2n1","inchiKey":"IDVQGNMSSHPZSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1618116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15622"]},"childChemblIds":["CHEMBL1256733"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1627367","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](F)[C@@H]2O","inchiKey":"KDLLNMRYZGUVMA-ZXXIGWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROESTRADIOL","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["16.alpha.-fluoroestradiol","Fluoroestradiol","Fluoroestradiol, 16.alpha.-"],"crossReferences":{"DailyMed":["fluoroestradiol%20f-18"]},"childChemblIds":["CHEMBL4594261"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for breast cancer."}
{"id":"CHEMBL1743054","drugType":"Antibody","blackBoxWarning":false,"name":"OZORALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATN 103","ATN-103","Ozoralizumab"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1762","canonicalSmiles":"Cc1cccc(C)c1NC(=O)C(C)N","inchiKey":"BUJAGSGYPOAWEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOCAINIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tocainide","W-36095"],"crossReferences":{"PubChem":["90341559"],"Wikipedia":["Tocainide"],"drugbank":["DB01056"],"chEBI":["9611"]},"childChemblIds":["CHEMBL1200773"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL184444","canonicalSmiles":"COC(=O)c1c(O)cccc1OC/C=C/c1cccc(-c2onc(C(=O)O)c2CO)c1","inchiKey":"DQSRCEFDWMQCCV-GQCTYLIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184444","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186113","canonicalSmiles":"CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(N[C@H](CO)Cc5ccccc5)nc43)[C@H](O)[C@@H]2O)n1","inchiKey":"FLBKPDIBGNWXMT-NIQZGXKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-328267","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW328267","GW328267X","Gw-328267","J2.047.755E"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL188225","canonicalSmiles":"O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@@H]12","inchiKey":"NAKUGCPAQTUSBE-IUCAKERBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL188225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855984"],"drugbank":["DB02414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189676","canonicalSmiles":"CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1","inchiKey":"HMXDWDSNPRNUKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURINABANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-147778","Sr147778","Surinabant"],"crossReferences":{"PubChem":["144210559"],"Wikipedia":["Surinabant"],"drugbank":["DB13070"]},"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL194805","canonicalSmiles":"CC(C)(c1ccccc1)c1ccc(O)cc1","inchiKey":"QBDSZLJBMIMQRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208495","144210376","17389498","26752848"],"drugbank":["DB06902"],"chEBI":["35092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203836","canonicalSmiles":"NC(=O)c1cc(C(=O)O)cc(-c2ccc(-c3ccccc3)cc2)c1","inchiKey":"LAZPCGBRHLARSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203836","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04583"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL208427","canonicalSmiles":"O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1","inchiKey":"LLDXOPKUNJTIRF-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLABEGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gw427353","Solabegron"],"crossReferences":{"drugbank":["DB06190"]},"childChemblIds":["CHEMBL2107299"],"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2096631","canonicalSmiles":"O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]","inchiKey":"QCHSEDTUUKDTIG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"CLORAZEPATE DIPOTASSIUM","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1213252","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clorazepate dipotassium","Gen-xene","Tranxene","Tranxene sd"],"synonyms":["4306 CB","4306-CB","4306CB","AB 35616","ABBOTT-35616","CB 4306","CM 4306","Clorazepate dipotassium","Clorazepate dipotassium civ","Clorazepic acid dipotassium salt","Dipotassium clorazepate","Potassium Clorazepate","TR 19119"],"crossReferences":{"DailyMed":["clorazepate%20dipotassium"],"chEBI":["3762"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0006788","HP_0001250"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for anxiety disorder and seizure. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104103","canonicalSmiles":"NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc32)CC1","inchiKey":"QAZKXHSIKKNOHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCAPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clocapramine","Clocapramine hydrochloride","Y 4153 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["170465785"],"drugbank":["DB09003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104940","canonicalSmiles":"CCC(C)N(CC(O)c1cccn1Cc1ccccc1Cl)C(C)CC","inchiKey":"ZILPIBYANAFGMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIMINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diviminol","Viminol","Z 424","Z-424"],"crossReferences":{"drugbank":["DB13353"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105085","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(\\C)CCC=C(C)C","inchiKey":"ZPACYDRSPFRDHO-ROBAGEODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFARNATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA 688","DA-688","Gefanil","Gefarnate"],"crossReferences":{"PubChem":["144206536","170465908"],"drugbank":["DB12079"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2106389","canonicalSmiles":"CNC(=O)c1c(I)c(NC(=O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I","inchiKey":"SMQYOVYWPWASGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOCARMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iocarmic acid","MP 2032","MP-2032"],"crossReferences":{"PubChem":["170465965"],"drugbank":["DB13755"]},"childChemblIds":["CHEMBL3989542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106572","canonicalSmiles":"Cc1ccc(N2CCNCC2)c(S(=O)(=O)O)c1","inchiKey":"DCDFLGVJWQIRGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALDARET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caldaret"],"crossReferences":{"drugbank":["DB06231"]},"childChemblIds":["CHEMBL4297401"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106991","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](F)[C@@H](CO)O2)cc1Cl","inchiKey":"WKVDSZYIGHLONN-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALURIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["935-U-83","935U83","Raluridine"],"crossReferences":{"drugbank":["DB12894"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107906","drugType":"Unknown","blackBoxWarning":false,"name":"PLAGUE VACCINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plague vaccine"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107960","drugType":"Unknown","blackBoxWarning":false,"name":"POISON IVY EXTRACT, ALUM PRECIPITATED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aqua ivy, ap","Rhus tox antigen"],"synonyms":["Ae-poison ivy","Eastern poison ivy leaf","Poison ivy","Poison ivy extract, alum precipitated","Poison ivy leaf","Rhus radicans leaf","Toxicodendron radicans leaf"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108018","drugType":"Antibody","blackBoxWarning":false,"name":"ADECATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adecatumumab","MT-201"],"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108020","drugType":"Unknown","blackBoxWarning":false,"name":"BCG LIVE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bcg live","Bcg vaccine live intradermal (tice)"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108076","drugType":"Unknown","blackBoxWarning":false,"name":"PARAFFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3216","Hard paraffin","Paraffin","Paraffin wax","Paraffin, white soft","Paraffinum","Paraffinum durum","Petroleum wax","Petroleum wax, crystalline"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108106","drugType":"Unknown","blackBoxWarning":false,"name":"TOCOPHERSOLAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eastman vitamin e tpgs","Vedrop"],"synonyms":["TPG-S","TPGS","Tocofersolan","Tocophersolan"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108309","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CUSTIRSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Custirsen","ISIS-112989 FREE ACID","OGX-011 FREE ACID"],"linkedTargets":{"rows":["ENSG00000120885"],"count":1},"linkedDiseases":{"rows":["EFO_0003060","MONDO_0008315","EFO_0000311"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108328","drugType":"Protein","blackBoxWarning":false,"name":"AMILOMOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amilomotide","CAD-106","CAD106","Cad106"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108351","drugType":"Protein","blackBoxWarning":false,"name":"VOTUCALIS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REV-131","Rev131","Votucalis"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108465","drugType":"Unknown","blackBoxWarning":false,"name":"GINGER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phillips","Travel sickness","Travelcaps"],"synonyms":["Amomum angustifolium whole","Amomum zinziba whole","Ardraka whole","B1265","Curcuma longifolia whole","FEMA NO. 2520","FEMA NO. 2521","Gan jiang whole","Garden ginger whole","Ginger","Ginger whole","Jiang pi whole","Jiang whole","Pao jiang whole","Sheng jiang whole","Shunthi whole","Wbv181a2i6","Zingiber aromaticum whole","Zingiber cholmondeleyi whole","Zingiber missionis whole","Zingiber officinale","Zingiber officinale extract","Zingiber officinale rhizome","Zingiber officinale rhizome powder","Zingiber officinale rhizome tincture","Zingiber officinale root","Zingiber officinale whole","Zingiber sichuanense whole","Zingiber zingiber whole"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2108671","drugType":"Antibody","blackBoxWarning":false,"name":"ACTOXUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mdx-066"],"synonyms":["Actoxumab","MDX-066"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108682","drugType":"Cell","blackBoxWarning":false,"name":"TERGENPUMATUCEL-L","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tergenpumatucel-l"],"description":"Cell drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108881","drugType":"Antibody","blackBoxWarning":false,"name":"SEVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Protovir"],"synonyms":["EV2-7","MSL-109","SDZ MSL 109","Sevirumab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108986","drugType":"Protein","blackBoxWarning":false,"name":"ARGIPRESSIN TANNATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pitressin tannate (synthetic)"],"synonyms":["Argipressin","Argipressin tannate","CI-107"],"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109101","drugType":"Antibody","blackBoxWarning":false,"name":"FELVIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Felvizumab","SB 209763","SB-209763"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109434","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-GP100","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-GP100"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109475","drugType":"Antibody","blackBoxWarning":false,"name":"PG-102","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PG-102","Pg-102"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109582","drugType":"Antibody","blackBoxWarning":false,"name":"81C6 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["81C6","81c6 131i"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["MONDO_0024880","EFO_0000621","EFO_1000158"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL212432","canonicalSmiles":"N/C(=N\\C(=O)c1nc(Cl)c(N)nc1N)NCCCCc1ccc(OCC(O)CO)cc1","inchiKey":"NTRKMGDUWYBLMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"552-02","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297254"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL219445","canonicalSmiles":"COc1cc2ncnc(N3CC[C@@H](Oc4cnc5ccccc5n4)C3)c2cc1OC","inchiKey":"UBIIFKJMNRPNMT-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219445","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08391"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL226335","canonicalSmiles":"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"IKGXIBQEEMLURG-NVPNHPEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birutan","C.I. 75730","Globulariacitrin","Ilixanthin","Myrticolorin","NSC-115918","NSC-9220","Novarrutina","Osyritrin","Paliuroside","Quercetin 3-rutinoside","Quercetin-3-o-rutinoside","Rutin","Rutoside","Sophorin","Tanrutin","Violaquercetrin","Yunxianggan"],"crossReferences":{"PubChem":["144205498","144209800","170465691","26719694","29216321"],"drugbank":["DB01698"],"chEBI":["28527"]},"childChemblIds":["CHEMBL455260","CHEMBL1883743"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2322189","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)([O-])O.[Na+]","inchiKey":"JHXHBFDOOUMZSP-LJUKVTEVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfomycin disodium","Fosfomycin sodium","NSC-136017"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2355456","canonicalSmiles":"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"PCIOHQNIRPWFMV-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUTILIDE FUMARATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL533","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corvert","Ibutilide fumarate"],"synonyms":["Ibutilide fumarate","U-70226E"],"crossReferences":{"DailyMed":["ibutilide%20fumarate"],"PubChem":["144206557"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995. This drug has a black box warning from the FDA."}
{"id":"CHEMBL238103","canonicalSmiles":"COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12","inchiKey":"DBPMWRYLTBNCCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-488043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-488043"],"crossReferences":{"drugbank":["DB05532"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25105","canonicalSmiles":"N=C(N)c1ccc(OCCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"OQLKNTOKMBVBKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexamidine"],"crossReferences":{"Wikipedia":["Hexamidine"],"drugbank":["DB03808"],"chEBI":["87184"]},"childChemblIds":["CHEMBL561781","CHEMBL3216902"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for nasal congestion and eye infection."}
{"id":"CHEMBL257553","canonicalSmiles":"NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"TZHCXOMEOHEZDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257553","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25843","canonicalSmiles":"CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1","inchiKey":"YSGASDXSLKIKOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMACEMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-R-12924","FPL-12924","PR-934-423","PR-934423A","Remacemide"],"crossReferences":{"drugbank":["DB06458"]},"childChemblIds":["CHEMBL1448437"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267227","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21","inchiKey":"HCAWPGARWVBULJ-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELTA 8-TETRAHYDROCANNOBINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delta 8-tetrahydrocannobinol"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL269864","canonicalSmiles":"O=c1[nH]cnc2c(CN3C[C@H](O)[C@@H](CO)C3)c[nH]c12","inchiKey":"AFNHHLILYQEHKK-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULODESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bcx-4208"],"synonyms":["BCX-3408","BCX4208","Dadme-immucillin h","R-3421","Ulodesine"],"crossReferences":{"drugbank":["DB12353"]},"childChemblIds":["CHEMBL2107835","CHEMBL1213653"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL274119","canonicalSmiles":"CSCCC(N)C(=O)O","inchiKey":"FFEARJCKVFRZRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACEMETHIONINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pedameth"],"synonyms":["Acimetion","D,l-methionine","Dl-methionine","Dl-methioninum","FEMA NO. 3301","Lobamine","Methionine","Methionine dl-form","NSC-9241","Racemethionine"],"crossReferences":{"PubChem":["144205216"],"drugbank":["DB13972"],"chEBI":["16811"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280728","canonicalSmiles":"O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1","inchiKey":"GLLPUTYLZIKEGF-HAVVHWLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDOGREL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R 68070","R-68070","Ridogrel"],"crossReferences":{"drugbank":["DB01207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL281764","canonicalSmiles":"CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N","inchiKey":"WURGZWOTGMLDJP-ZCYANPAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TABIMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NN-703","NNC-26-0703","Nn703","Tabimorelin"],"crossReferences":{"PubChem":["26753275"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL301523","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"COLNVLDHVKWLRT-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3585","L-phenylalanine","Laevo-phenyl alanine","NSC-79477","Phenylalanine"],"crossReferences":{"PubChem":["124877007","124877010","26753740","4252550"],"Wikipedia":["Phenylalanine"],"drugbank":["DB00120"],"chEBI":["17295"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL311875","canonicalSmiles":"C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(N)=O","inchiKey":"YVUUZAPYLPWFHE-HXFGRODQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL311875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3125702","canonicalSmiles":"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1","inchiKey":"DRLCSJFKKILATL-YWCVFVGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-232","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 232","AMG-232","Amg 232","Amg-232","KRT-232","Krt-232","Mdm2 inhibitor amg-232","Navtemadlin"],"crossReferences":{"drugbank":["DB15299"]},"linkedTargets":{"rows":["ENSG00000141510","ENSG00000135679"],"count":2},"linkedDiseases":{"rows":["MONDO_0044903","MONDO_0019457","EFO_0000756","EFO_1001465","EFO_0000222","EFO_1001968","EFO_0002429","EFO_0000311","EFO_0006738","EFO_0002430","EFO_1001471","EFO_0000339","EFO_0000702","EFO_0001378","EFO_0000479"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3127326","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C","inchiKey":"PIDFDZJZLOTZTM-KHVQSSSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMBITASVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABT-267","Ombitasvir"],"crossReferences":{"drugbank":["DB09296"],"chEBI":["85183"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for hepatitis c virus infection and chronic hepatitis c virus infection and has 1 investigational indication."}
{"id":"CHEMBL317052","canonicalSmiles":"CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1","inchiKey":"LZPZPHGJDAGEJZ-AKAIJSEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGADENOSON","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lexiscan"],"synonyms":["Regadenoson monohydrate"],"crossReferences":{"DailyMed":["regadenoson"],"PubChem":["170465244"],"drugbank":["DB06213"]},"childChemblIds":["CHEMBL3989695"],"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0001645","EFO_1001154","EFO_0000319"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL32","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"FABPRXSRWADJSP-MEDUHNTESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOXIFLOXACIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avelox","Avelox i.v."],"synonyms":["Avelox","Avelox iv","Moxifloxacin","Vigamox","Zimoxin"],"crossReferences":{"DailyMed":["moxifloxacin%20hydrochloride"],"Wikipedia":["Moxifloxacin"],"drugbank":["DB00218"],"chEBI":["63611"]},"childChemblIds":["CHEMBL1200735","CHEMBL2326947","CHEMBL3765320"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 7 approved and 74 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL328190","canonicalSmiles":"Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1","inchiKey":"GXESHMAMLJKROZ-IAPPQJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LASOFOXIFENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lasofoxifene"],"crossReferences":{"Wikipedia":["Lasofoxifene"],"drugbank":["DB06202"]},"childChemblIds":["CHEMBL2113354"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL328250","canonicalSmiles":"CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2","inchiKey":"GJSLOMWRLALDCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADINAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adinazolam","U-41,123","U-41123"],"crossReferences":{"Wikipedia":["Adinazolam"],"drugbank":["DB00546"],"chEBI":["251412"]},"childChemblIds":["CHEMBL2106672"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3360203","canonicalSmiles":"COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1","inchiKey":"QINPEPAQOBZPOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PILARALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pilaralisib","SAR-245408","SAR245408","Sar-245408","XL-147","XL147"],"crossReferences":{"drugbank":["DB11772"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0011962","MONDO_0007254","EFO_0000574","EFO_0004230","EFO_0003060","EFO_0000519","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3414626","canonicalSmiles":"CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1","inchiKey":"LXFOLMYKSYSZQS-LURJZOHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINOMETOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPZ-005676","EPZ-5676","Pinometostat","Pinometostat anhydrous"],"crossReferences":{"drugbank":["DB12920"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544914","canonicalSmiles":"CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO","inchiKey":"MJUVRTYWUMPBTR-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZACAFTOR","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tezacaftor","VX-661"],"crossReferences":{"drugbank":["DB11712"]},"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for cystic fibrosis."}
{"id":"CHEMBL3544993","drugType":"Gene","blackBoxWarning":false,"name":"AGLATIMAGENE BESADENOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Canatak","Gliatak","Oncatak","Pancatak","Prostatak","Virafir"],"synonyms":["AdV-tk","Aglatimagene besadenovec","Prostata"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3545137","canonicalSmiles":"Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1","inchiKey":"YFNWWNRZJGMDBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00477736","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-00477736","PF-477736","Pf-00477736"],"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545191","drugType":"Antibody","blackBoxWarning":false,"name":"EVINACUMAB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evkeeza"],"synonyms":["Evinacumab","Evinacumab-dgnb","REGN-1500","REGN1500"],"linkedTargets":{"rows":["ENSG00000132855"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","EFO_0000589","HP_0003124","Orphanet_391665","EFO_0004911"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for homozygous familial hypercholesterolemia and familial hypercholesterolemia and has 3 investigational indications."}
{"id":"CHEMBL3545281","drugType":"Small molecule","blackBoxWarning":false,"name":"AKN-028","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Akn-028"],"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545335","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1","inchiKey":"JXSVVZKPEDIRTN-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AG-13958","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG 13958","Ag-13958"],"childChemblIds":["CHEMBL3922529"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545343","drugType":"Small molecule","blackBoxWarning":false,"name":"ADC3680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC3680B","Adc3680"],"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0010638","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545383","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7167","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rg-7167"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3546168","canonicalSmiles":"Cl[Te]1(Cl)OCCO1","inchiKey":"ITUKXRCBQPSCQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3392104","CHEMBL4299068"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL356002","canonicalSmiles":"CC(=O)N/C(=C\\c1ccc(CC(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"NKMPOVPTYDXGEC-MNRBYUMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361348","canonicalSmiles":"CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(N[C@H]3CC[C@H](N)CC3)nc12","inchiKey":"MDIWBYRNTPTYQI-QAQDUYKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361348","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3670800","canonicalSmiles":"Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1","inchiKey":"DWKNOLCXIFYNFV-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAZUCIRNON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKST-4290","AKST4290","ALK-429","ALK-4290","ALK429","ALK4290","Akst4290","Alk-4290","Alk4290","BI144807","Lazucirnon"],"crossReferences":{"drugbank":["DB15269"]},"childChemblIds":["CHEMBL4594296"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707306","canonicalSmiles":"N#Cc1c(N(CC(=O)[O-])CC(=O)[O-])sc(C(=O)[O-])c1CC(=O)[O-].[Sr+2].[Sr+2]","inchiKey":"XXUZFRDUEGQHOV-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM RANELATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107175","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protelos"],"synonyms":["Distrontium renelate","Osseor","Ranelic acid strontium salt","Strontium ranelate","Strontium ranelate anhydrous","Strontium ranelate nonahydrate"],"crossReferences":{"DrugCentral":["4714"],"drugbank":["DB09267"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL3707395","canonicalSmiles":"CSc1ccc(C(=O)/C=C/c2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1","inchiKey":"AFLFKFHDSCQHOL-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELAFIBRANOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elafibranor","GFT-505","GFT505","Gft505"],"crossReferences":{"drugbank":["DB05187"]},"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951"],"count":2},"linkedDiseases":{"rows":["EFO_0003095","EFO_0001421","EFO_1001248","EFO_1001486","MONDO_0005148"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL386630","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"MUMGGOZAMZWBJJ-DYKIIFRCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Androderm","Androgel","Androgel 1%","Andropatch","Axiron","Fortesta","Intrinsa","Natesto","Striant","Striant sr","Testim","Testim 1%","Testoderm","Testoderm tts","Testogel","Testopatch","Testopel","Testoral","Testosterone","Tostran","Vogelxo"],"synonyms":["Delatestryl","NSC-9700","TESTIM","Testosterone","Testosterone ciii"],"crossReferences":{"DailyMed":["testosterone"],"PubChem":["144207887","17389513","50085980","56462804"],"Wikipedia":["Testosterone"],"drugbank":["DB00624"],"chEBI":["17347"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0002970","MONDO_0002009","EFO_0004234","EFO_1001919","Orphanet_478","MONDO_0018555","EFO_0003964","EFO_1000653","MONDO_0002146","EFO_0004714","EFO_0003144","EFO_0003884","EFO_0000196","EFO_0004215","HP_0000044","Orphanet_145","EFO_0000765","EFO_0005088","EFO_0000545","EFO_0001645","EFO_1001006","HP_0001657","EFO_0009867","EFO_0001073","MONDO_0008315","HP_0030016","EFO_0001663","EFO_0000660","EFO_0000311","EFO_1001078","GO_0007568","EFO_0000195","Orphanet_90695","MONDO_0100096","MONDO_0005301","HP_0003549","EFO_0002614","EFO_0000764","EFO_1000859","MONDO_0043510","HP_0001510","Orphanet_325690","EFO_0003922"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 4 approved and 30 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL39221","canonicalSmiles":"N[C@H](C(=O)O)c1cc(O)cc(O)c1","inchiKey":"HOOWCUZPEFNHDT-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-3,5-Dihydroxyphenylglycine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-3,5-Dihydroxyphenylglycine"],"crossReferences":{"PubChem":["11111063","11113456","11113714","26751901","50104578","50104579","90340619"],"drugbank":["DB04228"],"chEBI":["29474"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989948","canonicalSmiles":"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](OC)CC2)C3)c1","inchiKey":"WKDNQONLGXOZRG-HRNNMHKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANABECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3293","AZD3293","LY-3314814","LY3314814","Lanabecestat"],"crossReferences":{"drugbank":["DB14814"]},"childChemblIds":["CHEMBL3989942"],"linkedTargets":{"rows":["ENSG00000186318"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0001421","MONDO_0004975"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL400599","canonicalSmiles":"CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1","inchiKey":"CJAVTWRYCDNHSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENFLUOREX","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"," Respiratory toxicity"],"year":2009},"tradeNames":[],"synonyms":["Benfluorex","Mediaxal","NSC-757396"],"crossReferences":{"PubChem":["56320700"],"Wikipedia":["Benfluorex"],"drugbank":["DB09022"]},"childChemblIds":["CHEMBL1412305"],"linkedTargets":{"rows":["ENSG00000057252"],"count":1},"linkedDiseases":{"rows":["EFO_0000400","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in European Union  in 2009 due to Cardiotoxicity and  Respiratory toxicity."}
{"id":"CHEMBL4076837","canonicalSmiles":"CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1","inchiKey":"VNADJTWHOAMTLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SENEXIN B","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCD-115","Bcd-115","Senexin b"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4161733","canonicalSmiles":"C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1","inchiKey":"KRTIYQIPSAGSBP-ZACQAIPSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4161733","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4205422","canonicalSmiles":"O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1","inchiKey":"XCGJIFAKUZNNOR-QCKZDCLWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0752","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-0752"],"crossReferences":{"drugbank":["DB12852"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4282338","canonicalSmiles":"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc([S@](=N)(=O)C3CC3)cc2)ncc1C(F)(F)F","inchiKey":"UELYDGOOJPRWGF-SRQXXRKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4282338","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297213","canonicalSmiles":"CC(=O)O.CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"LBIUKNXYUXOWFF-CRYSLBJVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AFAMELANOTIDE ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL441738","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Scenesse"],"synonyms":["A-melanotropin, 4(nle)-7(d-phe)","Afamelanotide acetate","Afamelanotide triacetate","CUV1647 ACETATE"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297296","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1","inchiKey":"XAYAKDZVINDZGB-BMVMHAJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KOS-1584","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(e)-9,10-dehydroepothilone d","(e)-9,10-didehydroepothilone d","Dehydelone","Kos-1584","R-1645","R1645"],"crossReferences":{"drugbank":["DB05903"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297301","canonicalSmiles":"[2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H]","inchiKey":"OEYIOHPDSNJKLS-GQALSZNTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL-D9-CHOLINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL920","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(tri(2h3)methylaminio)ethanol","J2.078.736H","Methyl-d9-choline"],"crossReferences":{"drugbank":["DB12628"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297485","canonicalSmiles":"Cc1ccncc1N1CCN(c2ccnc(Cl)c2)C1=O","inchiKey":"ZVIFCOOHWGNPHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CFG-920","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CFG-920","CFG920","Cfg-920","Cfg920","LAE-001","LAE001","Lae001"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297562","drugType":"Unknown","blackBoxWarning":false,"name":"DKN-01","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DKN-01","Dkn-01","LY-2812176","LY2812176","Sirexatamab"],"linkedTargets":{"rows":["ENSG00000107984"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0000182","EFO_0001378","MONDO_0008315"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297622","canonicalSmiles":"C[C@@H]1OC(=O)N[C@@H]1C(=O)N[C@@H](Cc1cscn1)C(=O)N1CCC[C@H]1C","inchiKey":"WTXWDXWZGJGIHV-URBCHYCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVATIRELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPS-0373","Kps-0373","Rovatirelin","S-0373"],"crossReferences":{"drugbank":["DB15338"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297676","canonicalSmiles":"Cl.O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F","inchiKey":"HIEXZUXKTABHCP-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMASERTIB HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2107832","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 1036950","EMD-1036950","MSC-1936369B","MSC1936369B","Msc1936369b","Pimasertib hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297781","drugType":"Unknown","blackBoxWarning":false,"name":"MCLA-158","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCLA-158","Mcla-158"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297821","drugType":"Unknown","blackBoxWarning":false,"name":"RSLV-132","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rslv-132"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297991","drugType":"Unknown","blackBoxWarning":false,"name":"IMGN-632","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-632","IMGN632","Imgn-632","Imgn632"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298000","drugType":"Antibody","blackBoxWarning":false,"name":"ONVATILIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-61610588","JNJ61610588","Jnj-61610588","Onvatilimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4299851","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(F)nc1)C(=O)O)C(=O)O","inchiKey":"OLWVRJUNLXQDSP-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DCFPYL","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dcfpyl","Piflufolastat"],"childChemblIds":["CHEMBL4297334"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and has 3 investigational indications."}
{"id":"CHEMBL442951","canonicalSmiles":"CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HOVAGTYPODGVJG-VOQCIKJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Methyl Beta-D-Galactopyranoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Beta-D-Galactopyranoside","Methyl Beta-D-Galactoside"],"crossReferences":{"PubChem":["24823989"],"drugbank":["DB04046"],"chEBI":["17540"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443064","canonicalSmiles":"O=C(O)CCCCc1ccccc1","inchiKey":"BYHDDXPKOZIZRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-PHENYLVALERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Phenylvaleric Acid"],"crossReferences":{"drugbank":["DB04051"],"chEBI":["40131"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594244","drugType":"Small molecule","blackBoxWarning":false,"name":"HYALURONATE SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Legend"],"synonyms":["Hyaluronan sodium","Hyaluronate sodium","Hyaluronic acid sodium salt","Hyaluronic acid, sodium salt","Hyruan plus","Ostenil","Sodium hyaluronate","Sodium hyaluronate for ir identification"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for skin ulcer and nasal congestion and has 8 investigational indications."}
{"id":"CHEMBL4594410","canonicalSmiles":"COc1ccc(S(=O)(=O)NCc2cc(CN3CCCC3)c(O)c(CN3CCCC3)c2)cc1.O=S(=O)(O)O","inchiKey":"BQCSIJGCWZAHPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCARDINE SULFATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3638051","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBI-3000","Hbi-3000","Sulcardine sulfate","Sulcardine sulfate anhydrous"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594462","drugType":"Unknown","blackBoxWarning":false,"name":"AVB-S6-500","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVB S6 500","AVB-S6-500","AVBS6500","Avb-s6-500","Axl fc fusion protein avb-s6-500","Batiraxcept","RUGA-S6"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL46102","canonicalSmiles":"CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1","inchiKey":"SMTZFNFIKUPEJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXATIDINE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pifatidine","Roxatidine acetate"],"crossReferences":{"Wikipedia":["Roxatidine"],"drugbank":["DB08806"]},"childChemblIds":["CHEMBL2104871"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650478","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"SAPABLURSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 702843","ISIS-702843","Ionis tmprss6-lrx","Sapablursen"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL473119","canonicalSmiles":"Cc1n[nH]c2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12","inchiKey":"JYAHFMKZJRVTDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473119","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802146","canonicalSmiles":"CCCn1cc(-n2c(Cl)c(Sc3cccc(C(=O)O)c3F)c3ccc(Cl)c(F)c32)cn1","inchiKey":"NMDFAQXLJQRHMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-((2,6-DICHLORO-7-FLUORO-1-(1-PROPYL-1H-PYRAZOL-4-YL)-1H-INDOL-3-YL)THIO)-2-FLUOROBENZOIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluorobenzoic acid","BLD-0409","Bld-0409","PAT-409"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802175","drugType":"Unknown","blackBoxWarning":false,"name":"MK-2640","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-2640","Mk-2640"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802212","drugType":"Antibody","blackBoxWarning":false,"name":"FARLETUZUMAB ECTERIBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farletuzumab ecteribul","Farletuzumab ecteribulin","MORAb-202","Morab-202"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL491571","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12","inchiKey":"AVAACINZEOAHHE-VFZPANTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORIPENEM","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doribax","Finibax"],"synonyms":["Doripenem","S-4661"],"crossReferences":{"PubChem":["144206061","170465085"],"Wikipedia":["Doripenem"],"drugbank":["DB06211"]},"childChemblIds":["CHEMBL4303454","CHEMBL1276416"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 7 investigational indications."}
{"id":"CHEMBL499915","canonicalSmiles":"CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"OBZHEBDUNPOCJG-WBXJDKIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENOXOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbenoxolone"],"crossReferences":{"Wikipedia":["Carbenoxolone"],"drugbank":["DB02329"]},"childChemblIds":["CHEMBL1697717"],"linkedTargets":{"rows":["ENSG00000176387","ENSG00000117594"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for peptic ulcer and gastroesophageal reflux disease."}
{"id":"CHEMBL503090","canonicalSmiles":"O=C(Cc1ccc(F)cc1)NC(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1","inchiKey":"BMPOCDJEXAXXEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL503090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508338","drugType":"Small molecule","blackBoxWarning":false,"name":"THIMEROSAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Merthiolate"],"synonyms":["Ethylmercury sodium salt","Mercurothiolate","Merfamin","Mertorgan","Merzonin","NSC-4794","Sodium ethylmercurithiosalicylate","Thimerosal","Thiomersal","Thiomersalate"],"crossReferences":{"DrugCentral":["4733"],"PubChem":["144204884","144212493","170465469","26748268","26757844","57260470","57264345"],"Wikipedia":["Thiomersal"],"chEBI":["9546"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL52270","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"NKENBBIXEGPQLS-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-amino-4-deoxy-Neu5Ac2en","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-amino-4-deoxy-Neu5Ac2en"],"crossReferences":{"drugbank":["DB03321"]},"childChemblIds":["CHEMBL3330706"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL562317","canonicalSmiles":"c1ccc2nc(COc3ccc(-c4n[nH]cc4Cc4ccncc4)cc3)ccc2c1","inchiKey":"RQDDHVVAAJVVKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL562317","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL567204","canonicalSmiles":"Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1","inchiKey":"YZLKVEDFWLGNQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL567204","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL611940","canonicalSmiles":"O=C1N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=O)N1O","inchiKey":"IHDZZZHACPJCFJ-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL611940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02447"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6269","canonicalSmiles":"Cc1nccn1CCCCc1ccc(CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCCC2CCCCC2)cc1","inchiKey":"WHLPIOSHBKQGHA-KYJUHHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-58272","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-58272"],"crossReferences":{"drugbank":["DB02477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL645","canonicalSmiles":"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1","inchiKey":"VHYCDWMUTMEGQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOPROLOL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bisoprolol","CL 297,939","CL-297939","EMD 33 512","EMD-33-512","Zebeta","Ziac"],"crossReferences":{"DailyMed":["bisoprolol%20fumarate"],"PubChem":["174007419","26751965","29215032","50104637","90341096"],"Wikipedia":["Bisoprolol"],"drugbank":["DB00612"],"chEBI":["3127"]},"childChemblIds":["CHEMBL1200708","CHEMBL1472989"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["Orphanet_275766","EFO_0000275","EFO_0001645","EFO_0005252","MONDO_0007254","EFO_0009658","EFO_0000373","EFO_0000319","EFO_0000266","EFO_0000537","EFO_0003913","Orphanet_98896","MP_0001914","EFO_0008585","Orphanet_79292","MONDO_0001134","EFO_0003144","EFO_0008583","EFO_0000341","EFO_0008586"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for cardiovascular disease and hypertension and has 7 investigational indications."}
{"id":"CHEMBL65730","canonicalSmiles":"C=CCN(C)C/C=C/COc1cc2c(cc1F)c(-c1ccc(Br)cc1)nn2C","inchiKey":"YDWPQZUWZDRRSE-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65730","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02139"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL718","canonicalSmiles":"CC(N)(Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"CJCSPKMFHVPWAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPA (RACEMIC)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-3-(3,4-Dihydroxy-Phenyl)-2- Methyl-Propionic Acid(Catechol Metabolite)","Dl-.alpha.-methyl dopa","Dl-methyldopa","Methyldopa","Methyldopa (racemic)","Methyldopa dl-form","Racemic .alpha.-methyldopa"],"crossReferences":{"PubChem":["174006847","50106598","50106599","85231121","90340754"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL75435","canonicalSmiles":"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1","inchiKey":"DKYWVDODHFEZIM-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXKETOPROFEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Keral"],"synonyms":["(s)-ketoprofen","Arveles","Dexketoprofen","Ketoprofen, (s)-"],"crossReferences":{"PubChem":["26754382","26754383","56320640"],"drugbank":["DB09214"],"chEBI":["76128"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0100431","HP_0002829","MONDO_0005277","HP_0003326","EFO_1001139","EFO_0000616","EFO_1001412","EFO_0000677","HP_0003419","HP_0100607","MONDO_0002258","EFO_0003843","EFO_0005755"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication."}
